Hot off the breath: Mortality as a primary end-point in IPF treatment trials: The best is the enemy of the good

Athol U. Wells*, Juergen Behr, Ulrich Costabel, Vincent Cottin, Venerino Poletti, Luca Richeldi, C. Albera, J. Ancochea, K. M. Antoniou, P. Bonella, D. Bouros, P. Bresser, J. F. Cordier, B. Crestani, J. Domagala-Kulawik, M. Drent, J. J. Egan, T. Geiser, J. Grunewald, J. GruttersG. Gudmundsson, A. Guenther, S. Harari, N. K. Harrison, N. Hirani, U. Hodgson, C. M. Kahler, M. P. Keane, G. Kiter, M. Kneussl, T. M. Maher, N. Mogulkoc, J. Muller-Quernheim, C. Neurohr, H. Nunes, H. Parfrey, T. Peros-Golubicic, V. Polychronopoulos, G. Prevot, E. R. Renzoni, C. Robalo Cordeiro, C. Saltini, M. Skold, P. Spagnolo, M. Thomeer, S. Tomasseti, D. Valeyre, C. Vancheri, B. Wallaert, W. Wuyts, A. Xaubet

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

59 Citations (Scopus)
Original languageEnglish
Pages (from-to)938-940
Number of pages3
JournalThorax
Volume67
Issue number11
DOIs
Publication statusPublished - 1 Nov 2012
Externally publishedYes

Cite this